Citigroup Maintains Neutral on Nevro, Lowers Price Target to $21
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Joanne Wuensch has maintained a Neutral rating on Nevro (NYSE:NVRO) and lowered the price target from $24 to $21.
August 21, 2023 | 11:30 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Citigroup has maintained a Neutral rating on Nevro and lowered the price target from $24 to $21.
The lowering of the price target by Citigroup indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on Nevro's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100